✦ LIBER ✦
Chromodomain-Helicase-DNA-Binding Protein 7 (CHD7), a Novel Gemcitabine Sensitivity Gene, Is a Prognostic Biomarker in Patients With Early-Stage Resected Pancreatic Adenocarcinoma
✍ Scribed by Colbert, L.; Hardy, C.W.; Hall, W.A.; Fisher, S.B.; Saka, B.; Adsay, N.V.; Shelton, J.W.; Landry, J.C.; Maithel, S.K.; Yu, D.S.
- Book ID
- 122277526
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 64 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.